Preclinical models of prostate cancer—modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo

L Germain, C Lafront, V Paquette, B Neveu… - Nature Reviews …, 2023 - nature.com
Prostate cancer is well known to be dependent on the androgen receptor (AR) for growth
and survival. Thus, AR is the main pharmacological target to treat this disease. However …
被引用次数：7 相关文章

Preclinical models of prostate cancer-modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo.

L Germain, C Lafront, V Paquette, B Neveu… - Nature reviews …, 2023 - europepmc.org
Prostate cancer is well known to be dependent on the androgen receptor (AR) for growth
and survival. Thus, AR is the main pharmacological target to treat this disease. However …

Preclinical models of prostate cancer-modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo

L Germain, C Lafront, V Paquette… - Nature reviews …, 2023 - pubmed.ncbi.nlm.nih.gov
Prostate cancer is well known to be dependent on the androgen receptor (AR) for growth
and survival. Thus, AR is the main pharmacological target to treat this disease. However …